A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia.

Patients with breast cancer treated with MPA often report an improvement in appetite. Similar appetite stimulation is seen in patients treated with some corticosteroids, but MPA has a potential advantage over these drugs in that it does not exert a catabolic effect. MPA (100 mg tds orally) has there...

Descripción completa

Detalles Bibliográficos
Autores principales: Downer, S., Joel, S., Allbright, A., Plant, H., Stubbs, L., Talbot, D., Slevin, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968469/
https://www.ncbi.nlm.nih.gov/pubmed/8494706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968469/
https://www.ncbi.nlm.nih.gov/pubmed/8494706

Ejemplares similares